487 related articles for article (PubMed ID: 10168083)
1. Precipitating factors for pharmaceutical firms.
McCarthy R
State Health Care Am; 1997; ():39-43. PubMed ID: 10168083
[No Abstract] [Full Text] [Related]
2. The evolving role of pharmacy benefits management firms in a managed care environment.
O'Leary JS
Benefits Q; 1995; 11(3):24-33. PubMed ID: 10151118
[TBL] [Abstract][Full Text] [Related]
3. How well does your PBM perform?
McCarthy R
Bus Health; 1999 Jan; 17(1):24-9. PubMed ID: 10345211
[No Abstract] [Full Text] [Related]
4. Employers push to manage prescription drug costs.
Frieden J
Bus Health; 1992 May; 10(6):43-6, 48, 50. PubMed ID: 10119119
[No Abstract] [Full Text] [Related]
5. Pharmaceutical formularies: the right formula for cost and utilization?
Austin B
Find Brief; 2004 Aug; 7(5):1-3. PubMed ID: 15298009
[No Abstract] [Full Text] [Related]
6. Managing prescription drug costs.
Sica JM
Empl Benefits J; 2001 Mar; 26(1):35-40. PubMed ID: 11272515
[TBL] [Abstract][Full Text] [Related]
7. Is the market ready for direct pharmaceutical contracting by employers?
Giaquinta D
Manag Care Interface; 2004 Aug; 17(8):33-4. PubMed ID: 15471109
[No Abstract] [Full Text] [Related]
8. Wholesaling in the managed care market.
Toscano S
Med Interface; 1995 Dec; 8(12):78-81. PubMed ID: 10153522
[No Abstract] [Full Text] [Related]
9. Pharmaceutical manufacturers ... leaving tradition behind and forging new managed care alliances.
Barnett AA
State Health Care Am; 1995; ():41-6. PubMed ID: 10168072
[No Abstract] [Full Text] [Related]
10. Managing the drug benefit: one company's experience.
Kaye T
Manag Care; 2002 Jul; 11(7):34-8, 40. PubMed ID: 12219374
[No Abstract] [Full Text] [Related]
11. Specialty pharmacy management adjusts to new financial realities.
Reinke T
Manag Care; 2013 Apr; 22(4):13-4. PubMed ID: 23678558
[No Abstract] [Full Text] [Related]
12. Controlling the cost of branded drugs.
Mandelker J
Bus Health; 1993 Nov; 11(13):44-6, 48. PubMed ID: 10130506
[TBL] [Abstract][Full Text] [Related]
13. Pharmaceutical industry and payer partnerships to manage costs and improve quality.
Mauch RP
Manag Care; 2001 Sep; 10(9 Suppl):2-4; discussion 9-12. PubMed ID: 11729438
[No Abstract] [Full Text] [Related]
14. Strange symbiosis.
Navarro RP
Med Interface; 1996 Oct; 9(10):78-9, 82. PubMed ID: 10161514
[No Abstract] [Full Text] [Related]
15. Competition 101: managing demand to get quality care.
Enthoven A; Kronick R
Bus Health; 1988 Mar; 5(5):38-40. PubMed ID: 10286176
[No Abstract] [Full Text] [Related]
16. Doubts emerge about drug industry mergers.
Bus Health; 1994 Nov; 12(11):53-4, 56, 61. PubMed ID: 10138536
[No Abstract] [Full Text] [Related]
17. Managed care cost containment involving prescription drugs. American Medical Association, Council on Ethical and Judicial Affairs.
Food Drug Law J; 1998; 53(1):25-34. PubMed ID: 11795334
[No Abstract] [Full Text] [Related]
18. Shifting gears.
Tweed V
Bus Health; 1994 May; 12(5):28-9, 32, 34 passim. PubMed ID: 10134334
[No Abstract] [Full Text] [Related]
19. Redistribution of risk throughout the pharmaceutical industry.
Scheur BS
Med Interface; 1994 Oct; 7(10):77-80. PubMed ID: 10137569
[TBL] [Abstract][Full Text] [Related]
20. Reframing the pharmaceutical manufacturer/health plan relationship in managed care.
Studin I
Manag Care; 2002 Feb; 11(2):46, 49-54. PubMed ID: 11904913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
